• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏大小和肝血流量的年龄相关变化。对老年人药物代谢的影响。

Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly.

作者信息

Woodhouse K W, Wynne H A

机构信息

Department of Medicine (Geriatrics), University of Newcastle upon Tyne, England.

出版信息

Clin Pharmacokinet. 1988 Nov;15(5):287-94. doi: 10.2165/00003088-198815050-00002.

DOI:10.2165/00003088-198815050-00002
PMID:3203484
Abstract

The propensity of elderly people to suffer from dose-dependent adverse drug reactions is well known. This may be largely related to reduced drug clearance. Changes in liver size and liver blood flow are probably the main reason for this decline in drug elimination with age. This review focuses on methods of measuring liver size and blood flow, on changes which have been reported in the elderly and on the clinical implications of these changes.

摘要

老年人易发生剂量依赖性药物不良反应,这是众所周知的。这可能在很大程度上与药物清除率降低有关。肝脏大小和肝血流量的变化可能是药物消除随年龄下降的主要原因。本综述重点关注肝脏大小和血流量的测量方法、老年人中已报道的变化以及这些变化的临床意义。

相似文献

1
Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly.肝脏大小和肝血流量的年龄相关变化。对老年人药物代谢的影响。
Clin Pharmacokinet. 1988 Nov;15(5):287-94. doi: 10.2165/00003088-198815050-00002.
2
The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.衰老的肝脏。药物清除与氧扩散屏障假说。
Clin Pharmacokinet. 1998 May;34(5):359-73. doi: 10.2165/00003088-199834050-00003.
3
Hepatic drug metabolism and ageing.
Br Med Bull. 1990 Jan;46(1):22-35. doi: 10.1093/oxfordjournals.bmb.a072387.
4
Biological determinants of altered pharmacokinetics in the elderly.老年人药代动力学改变的生物学决定因素。
Gerontology. 1982;28 Suppl 1:8-17. doi: 10.1159/000212568.
5
Pharmacokinetics in older persons.老年人的药代动力学。
Am J Geriatr Pharmacother. 2004 Dec;2(4):274-302. doi: 10.1016/j.amjopharm.2004.12.005.
6
Hepatic drug metabolism and aging.肝脏药物代谢与衰老
Clin Pharmacokinet. 1990 Nov;19(5):359-89. doi: 10.2165/00003088-199019050-00002.
7
[Drug therapy in the elderly].[老年人的药物治疗]
Nihon Ronen Igakkai Zasshi. 1992 Jan;29(1):10-6. doi: 10.3143/geriatrics.29.10.
8
Drugs and the liver. Part III: Ageing of the liver and the metabolism of drugs.药物与肝脏。第三部分:肝脏衰老与药物代谢
Biopharm Drug Dispos. 1992 Jul;13(5):311-20. doi: 10.1002/bdd.2510130502.
9
[Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
Rinsho Byori. 1991 Oct;39(10):1093-7.
10
[Changes in pharmacokinetics in elderly patients].
Nihon Rinsho. 2013 Jun;71(6):999-1003.

引用本文的文献

1
A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement.肝脏衰老的生物标志物框架:衰老生物标志物联盟共识声明。
Life Med. 2024 Jan 30;3(1):lnae004. doi: 10.1093/lifemedi/lnae004. eCollection 2024 Feb.
2
Using deep learning to predict abdominal age from liver and pancreas magnetic resonance images.利用深度学习技术从肝脏和胰腺磁共振图像预测腹部年龄。
Nat Commun. 2022 Apr 13;13(1):1979. doi: 10.1038/s41467-022-29525-9.
3
Toxicokinetics of U-47700, tramadol, and their main metabolites in pigs following intravenous administration: is a multiple species allometric scaling approach useful for the extrapolation of toxicokinetic parameters to humans?

本文引用的文献

1
Effect of age on liver function with particular reference to bromsulphalein excretion.年龄对肝功能的影响,尤其涉及酚四溴酞磺酸钠排泄情况。
Gut. 1965 Jun;6(3):266-9. doi: 10.1136/gut.6.3.266.
2
THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN.人体肝血流量的估计
J Clin Invest. 1945 Nov;24(6):890-7. doi: 10.1172/JCI101676.
3
Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow.用酚四溴酞磺酸钠法测定人体内脏血流量:外周血浆酚四溴酞磺酸钠水平与计算血流量的关系。
U-47700、曲马多及其静脉给药后主要代谢物在猪体内的毒代动力学:多物种外推比例法是否可用于将毒代动力学参数外推至人体?
Arch Toxicol. 2021 Dec;95(12):3681-3693. doi: 10.1007/s00204-021-03169-y. Epub 2021 Oct 3.
4
Tacrolimus Dose-Conversion Ratios Based on Switching of Formulations for Patients with Solid Organ Transplants.基于实体器官移植患者制剂转换的他克莫司剂量转换比率
Can J Hosp Pharm. 2021 Fall;74(4):317-326. doi: 10.4212/cjhp.v74i4.3193.
5
Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression.健康受试者和治疗抵抗性抑郁症患者中艾司氯胺酮鼻喷雾剂及其代谢物去甲氯胺酮的群体药代动力学。
Clin Pharmacokinet. 2021 Apr;60(4):501-516. doi: 10.1007/s40262-020-00953-4. Epub 2020 Oct 31.
6
Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects.建立基于生理的药代动力学(PBPK)人群模型用于中国老年受试者。
Br J Clin Pharmacol. 2021 Jul;87(7):2711-2722. doi: 10.1111/bcp.14609. Epub 2021 May 18.
7
Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.避免药物性肝损伤(DILI)在一个老年住院队列中,使用更新的 RUCAM 评分评估因果关系的病例。
BMC Geriatr. 2020 Sep 14;20(1):346. doi: 10.1186/s12877-020-01732-3.
8
Large Cell Change in a Small Liver: A Histological Clue to Short Telomere Syndromes?小肝脏中的大细胞改变:短端粒综合征的组织学线索?
Hepatology. 2020 Dec;72(6):2231-2234. doi: 10.1002/hep.31272. Epub 2020 Dec 3.
9
Survivability of hospitalized chronic kidney disease (CKD) patients with moderate to severe estimated glomerular filtration rate (eGFR) after experiencing adverse drug reactions (ADRs) in a public healthcare center: a retrospective 3 year study.在一家公共医疗中心,中度至重度估算肾小球滤过率(eGFR)的住院慢性肾脏病(CKD)患者发生药物不良反应(ADR)后的生存能力:一项为期3年的回顾性研究。
BMC Pharmacol Toxicol. 2018 Aug 29;19(1):52. doi: 10.1186/s40360-018-0243-0.
10
Methods to reduce prescribing errors in elderly patients with multimorbidity.减少老年多病患者处方错误的方法。
Clin Interv Aging. 2016 Jun 23;11:857-66. doi: 10.2147/CIA.S80280. eCollection 2016.
J Lab Clin Med. 1950 Jun;35(6):923-32.
4
Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals.外科患者肝血流量的直接测量:以及对实验动物肝血流动力学的相关观察。
Ann Surg. 1962 Sep;156(3):463-71. doi: 10.1097/00000658-196209000-00013.
5
Estimation of hepatic blood flow with indocyanine green.用吲哚菁绿评估肝血流量。
J Clin Invest. 1962 May;41(5):1169-79. doi: 10.1172/JCI104570.
6
UNCERTAINTIES IN GERIATRIC DATA. II. ORGAN SIZE.老年医学数据中的不确定性。II. 器官大小。
J Am Geriatr Soc. 1965 Jan;13:20-8. doi: 10.1111/j.1532-5415.1965.tb00569.x.
7
VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.大鼠肝脏微粒体药物代谢酶活性随年龄的变化
Biochem Pharmacol. 1964 Jul;13:1037-51. doi: 10.1016/0006-2952(64)90100-5.
8
Observations on temperature, blood flow and heat production in the human liver in relation to environment and to glucose and insulin administration.关于人体肝脏温度、血流及产热与环境、葡萄糖和胰岛素给药关系的观察
Clin Sci. 1962 Feb;22:125-40.
9
The use of indocyanine green for the evaluation of hepatic function and blood flow in man.吲哚菁绿在人体肝功能及血流评估中的应用。
Am J Dig Dis. 1960 May;5:427-36. doi: 10.1007/BF02232628.
10
The disappearance rate of colloidal radio-gold from the circulation and its application to the estimation, of liver blood flow in normal and cirrhotic subjects.胶体放射性金在循环中的消失率及其在正常人和肝硬化患者肝血流量估计中的应用。
J Clin Invest. 1954 Dec;33(12):1594-602. doi: 10.1172/JCI103039.